CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-09 | Tan Kevin CFO & Treasurer | Option exercise | +11,250 | 28,862 | ||
| 2025-01-09 | Tan Kevin CFO & Treasurer | Option exercise · Restricted Stock Units | −11,250 | 22,500 | ||
| 2025-01-06 | Ganot Ilan Director | Sale | −1,056 | $4.31 | $5K | 11,445 |
| 2025-01-06 | SMITH IAN F Director | Grant or award · Stock Option (Right to Buy) | +22,148 | 22,148 | ||
| 2025-01-06 | SMITH IAN F Director | Grant or award · Restricted Stock Units | +18,293 | 18,293 | ||
| 2025-01-03 | Ganot Ilan Director | Option exercise | +2,994 | 12,501 | ||
| 2025-01-03 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −2,994 | 5,988 | ||
| 2025-01-03 | SMITH IAN F Director | Option exercise | +3,255 | 112,972 | ||
| 2025-01-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −3,255 | 0 | ||
| 2024-12-03 | Hanrahan Jessie Chief Regulatory Officer | Sale | −4,610 | $5.60 | $26K | 14,235 |
| 2024-12-03 | Cumbo Alexander President and CEO | Sale | −11,114 | $5.60 | $62K | 38,484 |
| 2024-12-03 | Howton David T Chief Operating Officer | Sale | −5,072 | $5.60 | $28K | 15,663 |
| 2024-12-03 | Herzich Paul Chief Technology Officer | Sale | −2,777 | $5.60 | $16K | 12,182 |
| 2024-12-02 | Hanrahan Jessie Chief Regulatory Officer | Option exercise | +11,862 | 18,845 | ||
| 2024-12-02 | Hanrahan Jessie Chief Regulatory Officer | Option exercise · Restricted Stock Units | −11,862 | 23,725 | ||
| 2024-12-02 | Cumbo Alexander President and CEO | Option exercise | +28,612 | 49,598 | ||
| 2024-12-02 | Cumbo Alexander President and CEO | Option exercise · Restricted Stock Units | −28,612 | 57,225 | ||
| 2024-12-02 | Howton David T Chief Operating Officer | Option exercise | +13,051 | 20,735 | ||
| 2024-12-02 | Howton David T Chief Operating Officer | Option exercise · Restricted Stock Units | −13,051 | 26,103 | ||
| 2024-12-02 | Herzich Paul Chief Technology Officer | Option exercise | +7,239 | 14,959 |
Page 11 of 12 · 223 trades